Tissuetech
Latest round
- Series C
Last raised
- Apr 2019
Total raised
- $108M
Investors
- 3
About Tissuetech
Tissuetech, Inc.Founded in 2001 and headquartered in Miami, US, Tissuetech, Inc. specializes in regenerative medicine solutions.Tissuetech specializes in advanced regenerative healing solutions through its CryoTek® technology, preserving the structure and biological properties of human birth tissue allografts. Its core products include Prokera, AmnioGraft, AmnioGuard, and Neox, primarily used in ophthalmology and surgical settings to support tissue repair and regeneration.Tissuetech generates revenue through direct sales of its regenerative medicine products to healthcare facilities and practitioners.Tissuetech plans to introduce upcoming products designed to enhance tissue regeneration solutions. The company is targeting expansion into specific markets in Europe and Asia by 2025.
Who invested in Tissuetech
3 investors across 4 rounds
See all investors in Tissuetech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tissuetech
Who invested in Tissuetech?
Tissuetech has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tissuetech raised?
Tissuetech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Tissuetech last raise money?
Tissuetech's most recent round on record is a Series C, in Apr 2019.
What does Tissuetech do?
Tissuetech is a biotechnology company.
Where is Tissuetech headquartered?
Tissuetech is headquartered in Miami, US.
Which VCs invest in companies like Tissuetech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tissuetech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Tissuetech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.